Darren Cline
2017
In 2017, Darren Cline earned a total compensation of $2.4M as Former Executive Vice President, Commercial at Seattle Genetics, a 16% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $222,834 |
---|---|
Option Awards | $814,060 |
Salary | $453,108 |
Stock Awards | $888,290 |
Other | $16,709 |
Total | $2,395,001 |
Cline received $888.3K in stock awards, accounting for 37% of the total pay in 2017.
Cline also received $222.8K in non-equity incentive plan, $814.1K in option awards, $453.1K in salary and $16.7K in other compensation.
Rankings
In 2017, Darren Cline's compensation ranked 4,648th out of 14,666 executives tracked by ExecPay. In other words, Cline earned more than 68.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 4,648 out of 14,666 | 68th |
Division Manufacturing | 1,636 out of 5,772 | 72nd |
Major group Chemicals And Allied Products | 476 out of 2,075 | 77th |
Industry group Drugs | 368 out of 1,731 | 79th |
Industry Biological Products, Except Diagnostic Substances | 69 out of 313 | 78th |
Source: SEC filing on April 4, 2019.
Cline's colleagues
We found seven more compensation records of executives who worked with Darren Cline at Seattle Genetics in 2017.
2017
Clay Siegall
Seattle Genetics
Chief Executive Officer
2017
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2017
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2017
Todd Simpson
Seattle Genetics
Chief Financial Officer
2017
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Jean Liu
Seattle Genetics